To offer Vildagliptin for Diabetics in UAE
Biocon announced that NeoBiocon, a collaboration between the Company and Dr B R Shetty, Chairman of UAE based Neopharma, has partnered with Novartis Middle East FZE, to market Jalra (Vildagliptin) and Jalra-M (Vildagliptin + Metformin) in UAE. This partnership will help NeoBiocon expands its product offerings in the metabolics segment and will immensely benefit diabetics in UAE.Powered by Capital Market - Live News